| |
FEE STRUCTURE
All projects are not alike and they need not take up the same resources. How then can we have one single fee structure for all our clients?
A major effort for our clients and us is in understanding the pathways and mechanism of actions of the drug candidates even before they become candidates. The consequence of working at this level is that there are many unknowns in the research and discovery phases. Sometimes, project work deviates from the expected timelines due to unexpected outcomes.
In order to economically carry out our work and give the best results we have two fee structures.
- Fixed fee, which typically works when the client is very clear about what they want and the outcome is certain.
• For example, it could be reproducing known protein purification conditions for a large HTS screen.
• Or it could be an iterative crystallography program based on well-documented PDB entries.
• Or it could be XRPD characterization of almost ready API.
- FTE pricing is recommended when it is such an early stage project that the outcomes can be many. And each outcome then feeds into the next step. XTAL nor the client actually know when the task will be finished so a defined time-line is impossible to draw. Of course this does not mean that the project can stretch forever! There are absolute deadlines and milestones attached to this type of pricing as well. We recommend this for:
• Projects where protocols need to be developed.
• Projects that are exploratory in nature and need some parallel approaches.
• Multiple projects need to be initiated at the same time. Then it makes more financial sense to move to an FTE model as opposed to the per project pricing.
• Project scope is quite big and may require shift in talent or resources as the need arises.
• Part-time consultation is required to assist in other programs.
|
 |
 OUR FOCUS >
X-Ray Crystallography
Construct Design
Protocol Development
Crystallograpgy Grade
Protein Purification
Crystallization Screening
Co-Crystal Production
> Learn More
|
CLIENT LOGIN
